Pfizer on Friday said it would quit fostering the two times day to day form of its exploratory weight reduction pill after stout patients taking the medication lost critical weight however experienced difficulty enduring the medication in a mid-stage clinical review.

Related Videos :







Pfizer Abandons Twice-Daily Weight Loss Pill as Patients Struggle; Once-Daily Version Under Scrutiny [qYY4jBrwS]

Pfizer Abandons Twice-Daily Weight Loss Pill as Patients Struggle; Once-Daily Version Under Scrutiny [qYY4jBrwS]

Pfizer on Friday said it would quit fostering the two times day to day form of its exploratory weight reduction pill after stout patients taking the medication lost critical weight however experienced difficulty enduring the medication in a mid-stage clinical review.

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now